期刊文献+

添加Si对Mg-6Al-1Zn合金显微组织、力学性能、生物腐蚀和细胞毒性的影响(英文) 被引量:7

Effect of addition of Si on microstructure, mechanical properties, bio-corrosion and cytotoxicity of Mg-6Al-1Zn alloy
下载PDF
导出
摘要 用机械合金化和热压法制备可降解的Mg-6Al-4Zn金属植入体。通过X射线衍射分析、透射电镜、压缩试验、浸泡试验、电化学测试和MTT比色法研究添加1%Si(质量分数)对Mg-6Al-1Zn合金显微组织、力学性能、生物腐蚀行为和细胞毒性的影响。结果显示,添加1%Si后,Mg-6Al-1Zn中形成了细小的多边形Mg2Si相,材料的抗压强度、伸长率和耐腐蚀性能提高,且骨肉瘤(Saos-2)细胞的细胞活性提高。根据MTT测试结果,释放出的镁离子没有细胞毒性。因此,添加1%Si提高了Mg-6Al-4Zn作为可降解植入体的综合性能。 The Mg-6Al-4Zn alloy was fabricated by mechanical alloying(MA)and hot pressing to serve as biodegradable metal implant.The influence of addition of 1%Si(mass fraction)on the microstructure,mechanical properties and bio-corrosion behavior of Mg-6Al-1Zn alloy was studied using X-ray diffractometry,transmission electron microscopy,compression test,as well as immersion,electrochemical test and MTT assay.The results showed that the addition of 1%Si to Mg-6Al-1Zn alloy led to the formation of fine Mg2Si phase with polygonal shape,and increased compressive strength,elongation and improved corrosion resistance.Furthermore,the cell viability of Saos-2 cells has been improved by addition of 1%Si to Mg-6Al-1Zn alloy.According to the results,the magnesium ions released in the methylthiazol tetrazolium(MTT)test have not shown any cell toxicity.All these indicated that the addition of 1%Si improved the properties of Mg-6Al-4Zn alloy for using as a biodegradable implant.
作者 M.AMIRNEJAD M.RAJABI A.MOTAVALLI M.AMIRNEJAD;M.RAJABI;A.MOTAVALLI(Department of Materials Science and Engineering,Faculty of Mechanical Engineering,Babol Noshirvani University of Technology,P.O.Box 47148-71167,Shariati Street,Babol,Iran)
出处 《Transactions of Nonferrous Metals Society of China》 SCIE EI CAS CSCD 2018年第9期1755-1762,共8页 中国有色金属学报(英文版)
关键词 镁基合金 机械合金化 力学性能 腐蚀速率 细胞活性 Mg-based alloy mechanical alloying mechanical properties corrosion rate cell viability
  • 相关文献

参考文献6

二级参考文献238

  • 1G.L. Song, S.Z. Song, Adv. Eng. Mater. 9 (2007) 298-302.
  • 2F. Witte, V. Kaese, H. Haferkamp, E. Switzer, A. Meyer-Lindenberg, C.J. Wirth, H. Windhagen, Biomaterials 26 (2005) 3.
  • 3J.C. Gao, S. Wu, L.Y. Qiao, Y. Wang, Trans. Nonferrous Met. Soc. China 18 (2008) 588-592.
  • 4B. Heublein, R. Rohde, V. Kaese, M. Niemeyer, W. Hartung, A. Haverich, Heart 89 (2003) 651-656.
  • 5C.D. Mario, H. Griffiths, O. Goktekin, J. Interv. Cardiol. 17 (2004) 391-395.
  • 6P. Peeters, M. Bosiers, J. Verbist, K. Deloose, B. Heublein, J. Endovascular Ther. 12 (2005) 1-5.
  • 7R. Erbel, C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, F.R. Eberli, P. Erne, M. Haude, B. Heublein, M. Horriga.
  • 8R. Waksman, EuroIntervention 5 (2009) FI03-FI08.
  • 9S.S.A. El-Rahman, Pharmacol. Res. 47 (2003) 189-194.
  • 10Y Nakamura, Y Tsumura, Y. Tonogai, T. Shibata, Y Ito, Toxicol. Sci. 37 (1997) 106-116.

共引文献89

同被引文献119

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部